bioRxivMolecular BiologyPreprint
TMC5 promotes lung adenocarcinoma cell proliferation, migration and invasion by regulating epithelial-mesenchymal transition
Abstract
Background/purposeIn recent years, evidence has indicated that transmembrane channel-like 5 (TMC5) plays an important role in various cancers. Previously, one study showed that TMC5 was highly expressed in lung adenocarcinoma (LUAD), but its mechanism in LUAD remained unclear. In this study, we aimed to investigate the effects of TMC5 and its underlying mechanisms in LUAD progression. MethodsThe expression level of TMC5 in LUAD tissues was detected by real-time quantitative PCR. TMC5 was knocked down in A549 and H1437 cell lines using lentiviral transfection. The oncogenic effect of TMC5 on LUAD cell proliferation was evaluated by CCK-8 assay and colony formation assay. Transwell assay was employed to assess migration and invasion. ResultsTMC5 was overexpressed in LUAD tissues compared with normal tissues. Suppression of TMC5 expression reduced proliferation, migration, and invasion, while also decreasing the expression of mesenchymal markers and increasing epithelial markers in A549 and H1437 cells. Conversely, higher TMC5 expression significantly increased the expression of mesenchymal markers and decreased epithelial markers. ConclusionTMC5 facilitates the malignant behaviors of LUAD cells by regulating epithelial-mesenchymal transition, suggesting its potential as a promising diagnostic and therapeutic target.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- LINC01117 inhibits invasion and migration of lung adenocarcinoma through influencing EMT process
Linjun Liu, Wenjia Ren, … Yubai Zhou·PLoS ONEPeer-reviewed·Jun 29, 2023
- TGF-β induces an atypical EMT to evade immune mechanosurveillance in lung adenocarcinoma dormant metastasis
Zhenghan Wang, Yassmin A. Elbanna, … Joan Massagué·Nature CancerPeer-reviewed·Jan 5, 2026
- Simultaneous immunomodulation and epithelial-to-mesenchymal transition drives lung adenocarcinoma progression
Junbum Kim, Hiranmayi Ravichandran, … Olivier Elemento·bioRxiv·Feb 19, 2025
- Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition
A. J. Mannion, A. F. Odell, … G. P. Cook·Frontiers in Cell and Developmental BiologyPeer-reviewed·Apr 17, 2023
- Tenascin-C in the early lung cancer tumor microenvironment promotes progression through integrin activation and FAK
Shiela C. Samson, Anthony Rojas, … Michelle C. Mendoza·bioRxiv·Sep 17, 2024
- Nuclear lamin A/C promotes cancer cell survival and lung metastasis without restricting transendothelial migration
F. Roncato, O. Regev, … R. Alon·CancersPeer-reviewed·May 14, 2021